Search Results 2601-2610 of 13650 for monoclonal antibody
Part 3: prior BCMA targeted bispecific antibody therapy; prior GPRC5D targeted therapy. - Allogeneic stem cell transplant within 6 months before the first ...
... antibody) * Olaparib (a type of PARP inhibitor). Olaparib, Cediranib Maleate, and Standard Chemotherapy in Treating Patients With Small Cell Lung Cancer.
These therapeutic antibodies and their derivatives have transformed the therapeutic landscape of cancer patients. Only 20% of cell-surface proteins have ...
It works by causing your immune system to produce its own protection (antibodies) against the virus. This vaccine is to be given only by or under the ...
The vaccine works by causing your body to produce its own protection (antibodies) against the disease. Infections with Haemophilus influenza type b (Hib) ...
Related. Associated Procedures. Bispecific antibody therapy · Blood transfusion · Gene therapy. Products & Services. A Book: Mayo Clinic Family Health Book ...
The purpose of this study is to evaluate the safety, clinical pharmacology and clinical activity of TNB-383B, a T-cell engaging bispecific antibody, in ...
Virus (HIV) (positive HIV-1/2 antibodies) Prior or second invasive malignancy, except nonmelanoma skin cancer, completely resected cervical carcinoma in ...
Positive anti-double-stranded deoxyribonucleic acid (anti-dsDNA) antibody test at Screening. Known hypersensitivity to DCR-PHXC or any of its ingredients ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.